Tumor‐Associated Macrophages in the Chemoresistant Microenvironment of Gastric Cancer: Key Mechanisms and Intercellular Crosstalk
Cell Biology International · 2026-09 · 50 (9)
DOI: 10.1002/cbin.70203 ↗At a glance
Übersichtsarbeit in Cell Biology International, published online on 2026-08-26. Written by Saeb Younis Abdul-Rahman and 11 co-authors. Institution: Department of Anesthesia Techniques, Health and Medical Techniques College, Alnoor University, Mosul, Iraq. Major MEDLINE topics: Stomach Neoplasms, Tumor Microenvironment, Drug Resistance, Neoplasm, Tumor-Associated Macrophages. 72 references. The full text is freely available in PubMed Central.
Abstract (original language)
Gastric cancer (GC) remains a leading cause of cancer‐related mortality, with chemoresistance posing a critical barrier to effective treatment. Tumor‐associated macrophages (TAMs), particularly the immunosuppressive M2‐polarized subset, are emerging as pivotal mediators of chemoresistance within the tumor microenvironment (TME). TAMs promote resistance through multifaceted mechanisms, including activation of pro‐survival signaling pathways, induction of epithelial–mesenchymal transition (EMT), and enhancement of angiogenesis. For instance, M2‐like TAMs secrete CXCL5, which activates the PI3K/AKT/mTOR axis in GC cells, thereby conferring resistance to 5‐fluorouracil (5‐FU). Similarly, TMEM, a transmembrane protein overexpressed in cisplatin‐resistant GC, drives M2 polarization of TAMs via the Wnt/β‐catenin pathway, further amplifying drug resistance and tumor progression. Clinical studies reveal that high TAM infiltration correlates with poor chemotherapy response and reduced survival in GC patients. This review synthesizes current evidence on TAM‐driven chemoresistance in GC, highlighting the molecular interplay between TAMs, tumor cells, and stromal components. It underscores the potential of TAM‐centric therapies—including checkpoint inhibitors, epigenetic modulators, and combination regimens—to overcome resistance and improve clinical outcomes. By integrating preclinical insights and clinical data, this work provides a roadmap for developing precision therapies that exploit TAM biology to enhance chemosensitivity in GC.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Anesthesia Techniques, Health and Medical Techniques College, Alnoor University, Mosul, Iraq.
- Ahl al Bayt University, Kerbala, Iraq.
- Department of Biotechnology and Genetics, School of Sciences, JAIN (Deemed to be University), Bangalore, Karnataka, India.
- Department of Medical Oncology, IMS and SUM Hospital, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India.
- Department of Biomedical, Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu, India.
- Department of Physiotherapy, University Institute of Allied Health Sciences, Chandigarh University, Chandigarh, Punjab, India.
ORCID profiles: Saeb Younis Abdul-Rahman
Cite
APA
Abdul-Rahman, S. Y., Shareef, A., Jyothi, S. R., Nayak, P. P., Janney, J. B., Singh, G., Sinha, A., Ergasheva, M., Sameer, H. N., Yaseen, A., Salih, R. M., & Adil, M. (2026). Tumor‐Associated Macrophages in the Chemoresistant Microenvironment of Gastric Cancer: Key Mechanisms and Intercellular Crosstalk. Cell Biology International, 50(9). https://doi.org/10.1002/cbin.70203
Vancouver
Abdul-Rahman SY, Shareef A, Jyothi SR, Nayak PP, Janney JB, Singh G, et al. Tumor‐Associated Macrophages in the Chemoresistant Microenvironment of Gastric Cancer: Key Mechanisms and Intercellular Crosstalk. Cell Biology International. 2026;50(9). doi:10.1002/cbin.70203
BibTeX
@article{AbdulRahman2026,
author = {Abdul-Rahman, Saeb Younis and Shareef, Abdulkareem and Jyothi, S Renuka and Nayak, Priya Priyadarshini and Janney, J Bethanney and Singh, Gurjant and Sinha, Aashna and Ergasheva, Munisa and Sameer, Hayder Naji and Yaseen, Ahmed and Salih, Rasim M and Adil, Mohaned},
title = {Tumor‐Associated Macrophages in the Chemoresistant Microenvironment of Gastric Cancer: Key Mechanisms and Intercellular Crosstalk},
journal = {Cell Biology International},
year = {2026},
volume = {50},
number = {9},
doi = {10.1002/cbin.70203}
}
EUVIMED